Navigation Links
Lab-on-a-chip could speed up treatment of drug-resistant pneumonia

The emergency treatment of drug-resistant infections with targeted antibiotics is often delayed by the need to identify bacterial strains by growing them in culture first. At this week's AVS 53rd International Symposium & Exhibition in San Francisco, Michael Lochhead, a bioengineer at the Denver biotechnology company Accelr8, described a new lab-on-a-chip that can identify single bacterial cells for the most common cases of drug-resistant pneumonia, cutting down the wait from days to hours. The technology could also help in the development of new drugs.

The constant bombardment by antibiotics and disinfectants has bred strains of super-bugs that only respond to very specific drugs. These super-bugs often lurk in hospitals, where patients with weakened immune systems can pick up obstinate, life-threatening infections such as pneumonia. "When you get pneumonia in the hospital, you're much more likely to get a resistant strain," Lochhead said. "It's an emerging public-health disaster."

The most acute cases are admitted into intensive care units, where doctors have just days, if not hours, to save the patients' lives, Lochhead said. But reliably identifying the bacterial strain that's causing the infection traditionally requires growing the bugs in culture first, a procedure that can take two to three days. Meanwhile, doctors often have no other option than to start stopgap treatments with broad-spectrum antibiotics.

The Accelr8 technology is a "microfluidic" lab-on-a-chip designed to manipulate and analyze bacteria without growing them first. Samples are first washed out of the patient's lungs with saline solution in a procedure called bronchoalveolar lavage. The organisms are then separated, suspended in a specially designed fluid, and pumped into the chip.

Inside the chip, the bacteria flow into several different compartments -- eight in the current version of the chip -- and are made to stick to a bacteria-friendly surface us
'"/>

Source:American Institute of Physics


Page: 1 2 3

Related biology news :

1. Protein discovery could unlock the secret to better TB treatment
2. Tiny particles could solve billion-dollar problem
3. First atlas of key brain genes could speed research on cancer, neurological diseases
4. Discovery of key proteins shape could lead to improved bacterial pneumonia vaccine
5. A comprehensive response to HIV could prevent 10 million AIDS deaths in Africa by 2020
6. How the environment could be damaging mens reproductive health
7. Dead zone area in Gulf could be increasing, researchers say
8. Growth in biomass could put US on road to energy independence
9. Nano-bumps could help repair clogged blood vessels
10. Researchers develop assay that could be applied to drug screening
11. Currents could disrupt ocean food chain
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Lab chip could speed treatment drug resistant pneumonia

(Date:6/18/2015)... , June 18, 2015 NXT-ID, Inc. (NASDAQ: ... company focused on the growing mobile commerce market announces that ... featured segment on "Money on the Mark", scheduled to air ... June 20 th . The ... be from 7:00 to 8:00pm EST. NXT-ID, Inc.,s CEO ...
(Date:6/17/2015)... SAN JOSE, Calif. , June 17, 2015 ... leader in human interface solutions, today announced that ... has adopted the Synaptics ® ClearPad ® ... family of display driver integrated circuits (DDICs) for ... Note Pro. By leveraging ClearPad for full in-cell ...
(Date:6/16/2015)... 16, 2015  With the increasing number and severity ... top concern. The recent compromise of Federal employee ... strong authentication within government agencies. HYPR Corp. ... password (OTP) authenticator, has been submitted for testing and ... 3 validation for tamper proofing. The ...
Breaking Biology News(10 mins):NXT-ID, Inc.'s CEO Gino Pereira Talks About the Wocket Smart Wallet on WABC Radio, New York City, June 20th 2NXT-ID, Inc.'s CEO Gino Pereira Talks About the Wocket Smart Wallet on WABC Radio, New York City, June 20th 3Synaptics Touchscreen and Display Driver IC Solutions Power Xiaomi's Latest Flagship Smartphones 2Synaptics Touchscreen and Display Driver IC Solutions Power Xiaomi's Latest Flagship Smartphones 3Government Ready Biometric Security Approaching as HYPR Corp. Files FIPS 140-2 Level 3 Validation for Its Proprietary Biometric Token 2Government Ready Biometric Security Approaching as HYPR Corp. Files FIPS 140-2 Level 3 Validation for Its Proprietary Biometric Token 3
... in which the aging process is linked to DNA damage--which ... influences--and the various ways in which cells repair that damage. ... fruit flies make use of a different mix of molecular ... are reported by William Engels and colleagues at the University ...
... “vile and cynical exploitation?by the alternative medicines industry, argues a ... that up to 80% of all patients with cancer take ... treat their cancer, writes Jonathan Waxman, Professor of Oncology at ... use of many of these approaches is obtuse ?one might ...
... The widely used breast cancer drug tamoxifen (Nolvadex®), which ... full strength indefinitely if used along with a second ... investigators from the National Cancer Institute (NCI), part of ... results appear in the December 11, 2006, issue of ...
Cached Biology News:Age-related changes in DNA repair illuminate the connection between age and genetic damage 2Protect patients from exploitation by alternative medicines industry 2Restoring tamoxifen sensitivity in resistant breast cancer cells 2
(Date:7/3/2015)... ... July 03, 2015 , ... ... such as animal waste reduction, bioremediation, wastewater treatment, aquaculture and grease, fat ... today that it will be showcasing, ManureMagic™, its industry-leading product for animal ...
(Date:7/3/2015)... , July 3, 2015 ... till 22 september 2015 på  http://www.openinnovationinscience.at ... Innovation in Science" som hålls i ... en färsk undersökning med internationella forskare och ... (LBG) är hälsovetenskapens två största utmaningar bristen ...
(Date:7/2/2015)... (PRWEB) , ... July 03, 2015 , ... Cuvettes have been used in countless labs ... catalog to find the cuvette they needed. As expected, this was a daunting and ... the wrong part because they were not able to navigate the complex catalog structure. , ...
(Date:7/2/2015)... ... 2015 , ... Sleepless nights will become obsolete as Luzi , a ... campaign on June 23. Sound sleepers and the sleep deprived both will love Luzi ... while the integration of the Bluetooth speaker, alarm clock and ability to charge various ...
Breaking Biology Technology:DryLet to Highlight Benefits of Patented ManureMagic™ at North American Manure Expo in Chambersburg, PA July 14-15, 2015 2Lansering av världens första program för öppen innovation för att utbilda forskare 2Lansering av världens första program för öppen innovation för att utbilda forskare 3New Cuvette E-Commerce Website Launched by FireflySci 2Luzi Smart Lamp Recently Launched Indiegogo Campaign 2Luzi Smart Lamp Recently Launched Indiegogo Campaign 3
... Agendia BV, a,world leader in the rapidly evolving field ... Officer Laura van ,t Veer has,received a prestigious 2007 ... Cancer Research Foundation. The Pink Ribbon ,Breast Cancer ... breast cancer researchers with a total value of,32 M$. ...
... Oximetry Unit, NEW YORK, Oct. 22 SPO ... biosensor and microprocessor,technologies for use in portable monitoring devices, ... unit. This sales milestone has,been achieved within three years ... The bulk of the 100,000 units sold include the ...
... Holdings Asia and,its co-investors today announced that they ... the world,s largest privately held,crop- protection and life-science ... billion (US$2.2 billion). The sale will culminate a,five-year ... private,equity firm with investment teams in Japan, Greater ...
Cached Biology Technology:Agendia BV Announces That its Chief Research Officer Laura van 't Veer has Received a 2007 Breast Cancer Research Foundation Award 2SPO Medical Announces Major Sales Milestone 2SPO Medical Announces Major Sales Milestone 3Olympus Capital Announces Agreement to Sell Arysta LifeScience Corporation 2Olympus Capital Announces Agreement to Sell Arysta LifeScience Corporation 3